![Andrea Pederzolli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrea Pederzolli
Voorzitter bij
Laboratori Italiani Riuniti SpA
Profiel
Andrea Pederzolli is currently the Chairman at Laboratori Italiani Riuniti SpA since 2020.
Prior to this, he worked as a Fund Manager at Xyence Capital SGR from 2017 to 2021 and as a Director at Enterome SA.
Actieve functies van Andrea Pederzolli
| Bedrijven | Functie | Begin |
|---|---|---|
Laboratori Italiani Riuniti SpA
 Laboratori Italiani Riuniti SpA Miscellaneous Commercial ServicesCommercial Services Operates as an analysis laboratory | Voorzitter | 01-02-2020 |
Eerdere bekende functies van Andrea Pederzolli
| Bedrijven | Functie | Einde |
|---|---|---|
Xyence Capital SGR SpA
 Xyence Capital SGR SpA Investment ManagersFinance Xyence Capital invests in startup companies located in europe the United States and Italy. The firm targets companies operating in the field of electronic and health technology sector with particular focus in biotechnology and IT services. It provides equity for early to later stage as well as growth capital requirements with invests between EUR 0.5 to EUR 24 million. | Private Equity Investor | 01-05-2021 |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
3
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Xyence Capital SGR SpA
Xyence Capital SGR SpA Investment ManagersFinance Xyence Capital invests in startup companies located in europe the United States and Italy. The firm targets companies operating in the field of electronic and health technology sector with particular focus in biotechnology and IT services. It provides equity for early to later stage as well as growth capital requirements with invests between EUR 0.5 to EUR 24 million. | Finance |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Health Technology |
Laboratori Italiani Riuniti SpA
Laboratori Italiani Riuniti SpA Miscellaneous Commercial ServicesCommercial Services Operates as an analysis laboratory | Commercial Services |
Kies MarketScreener 
